Diabetes Care Devices Market Size to Hit USD 118.34 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Diabetes Care Devices Market

5.1. COVID-19 Landscape: Diabetes Care Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Diabetes Care Devices Market, By Product Type (Revenue and Volume)

8.1. Diabetes Care Devices Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

8.1.1. Blood Glucose Monitoring Devices (BGM)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Insulin Delivery Devices

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Other Diabetes Management Devices

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Diabetes Care Devices Market, By Diabetes Type

9.1. Diabetes Care Devices Market Revenue and Volume Forecast, by Diabetes Type

9.1.1. Type 1 Diabetes

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Type 2 Diabetes

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Gestational Diabetes

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Other Specific Types of Diabetes

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Diabetes Care Devices Market, By End User

10.1. Diabetes Care Devices Market Revenue and Volume Forecast, by End User

10.1.1. Hospitals & Specialty Clinics

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Home-Care Settings / Self-Care

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Diagnostic Centers

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Ambulatory Surgical Centers (ASCs)

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Physician Offices

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Diabetes Care Devices Market, By Distribution Channel

11.1. Diabetes Care Devices Market Revenue and Volume Forecast, by Distribution Channel

11.1.1. Hospital Pharmacies

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Retail Pharmacies

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Online Pharmacies / E-commerce & Direct-to-Consumer (D-to-C)

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Diabetes Clinics/Centers

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Wholesalers & Distributors

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Diabetes Care Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.1.2. Market Revenue and Volume Forecast, by Diabetes Type

12.1.3. Market Revenue and Volume Forecast, by End User

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.1.5.2. Market Revenue and Volume Forecast, by Diabetes Type

12.1.5.3. Market Revenue and Volume Forecast, by End User

12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.1.6.2. Market Revenue and Volume Forecast, by Diabetes Type

12.1.6.3. Market Revenue and Volume Forecast, by End User

12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.2.2. Market Revenue and Volume Forecast, by Diabetes Type

12.2.3. Market Revenue and Volume Forecast, by End User

12.2.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.2.5.2. Market Revenue and Volume Forecast, by Diabetes Type

12.2.5.3. Market Revenue and Volume Forecast, by End User

12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.2.6.2. Market Revenue and Volume Forecast, by Diabetes Type

12.2.6.3. Market Revenue and Volume Forecast, by End User

12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.2.7.2. Market Revenue and Volume Forecast, by Diabetes Type

12.2.7.3. Market Revenue and Volume Forecast, by End User

12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.2.8.2. Market Revenue and Volume Forecast, by Diabetes Type

12.2.8.3. Market Revenue and Volume Forecast, by End User

12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.3.2. Market Revenue and Volume Forecast, by Diabetes Type

12.3.3. Market Revenue and Volume Forecast, by End User

12.3.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.3.5.2. Market Revenue and Volume Forecast, by Diabetes Type

12.3.5.3. Market Revenue and Volume Forecast, by End User

12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.3.6.2. Market Revenue and Volume Forecast, by Diabetes Type

12.3.6.3. Market Revenue and Volume Forecast, by End User

12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.3.7.2. Market Revenue and Volume Forecast, by Diabetes Type

12.3.7.3. Market Revenue and Volume Forecast, by End User

12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.3.8.2. Market Revenue and Volume Forecast, by Diabetes Type

12.3.8.3. Market Revenue and Volume Forecast, by End User

12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.4.2. Market Revenue and Volume Forecast, by Diabetes Type

12.4.3. Market Revenue and Volume Forecast, by End User

12.4.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.4.5.2. Market Revenue and Volume Forecast, by Diabetes Type

12.4.5.3. Market Revenue and Volume Forecast, by End User

12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.4.6.2. Market Revenue and Volume Forecast, by Diabetes Type

12.4.6.3. Market Revenue and Volume Forecast, by End User

12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.4.7.2. Market Revenue and Volume Forecast, by Diabetes Type

12.4.7.3. Market Revenue and Volume Forecast, by End User

12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.4.8.2. Market Revenue and Volume Forecast, by Diabetes Type

12.4.8.3. Market Revenue and Volume Forecast, by End User

12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.5.2. Market Revenue and Volume Forecast, by Diabetes Type

12.5.3. Market Revenue and Volume Forecast, by End User

12.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.5.5.2. Market Revenue and Volume Forecast, by Diabetes Type

12.5.5.3. Market Revenue and Volume Forecast, by End User

12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type (Revenue and Volume)

12.5.6.2. Market Revenue and Volume Forecast, by Diabetes Type

12.5.6.3. Market Revenue and Volume Forecast, by End User

12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 13. Company Profiles

13.1. Abbott Laboratories

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Type (Revenue and Volume)ance

13.1.4. Recent Initiatives

13.2. Medtronic plc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Type (Revenue and Volume)ance

13.2.4. Recent Initiatives

13.3. F. Hoffmann-La Roche Ltd

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Type (Revenue and Volume)ance

13.3.4. Recent Initiatives

13.4. Dexcom, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Type (Revenue and Volume)ance

13.4.4. Recent Initiatives

13.5. Ascensia Diabetes Care (PHC Holdings)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Type (Revenue and Volume)ance

13.5.4. Recent Initiatives

13.6. LifeScan, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Type (Revenue and Volume)ance

13.6.4. Recent Initiatives

13.7. Insulet Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Type (Revenue and Volume)ance

13.7.4. Recent Initiatives

13.8. Tandem Diabetes Care, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Type (Revenue and Volume)ance

13.8.4. Recent Initiatives

13.9. B. Braun Melsungen AG

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Type (Revenue and Volume)ance

13.9.4. Recent Initiatives

13.10. Ypsomed AG

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Type (Revenue and Volume)ance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The diabetes care devices market size is expected to increase from USD 64.54 billion in 2024 to USD 118.34 billion by 2034.

The diabetes care devices market is expected to grow at a compound annual growth rate (CAGR) of around 6.25% from 2025 to 2034.

The major players in the diabetes care devices market include Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd, Dexcom, Inc., Ascensia Diabetes Care (PHC Holdings), LifeScan, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., B. Braun Melsungen AG, Ypsomed AG, Terumo Corporation, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Glooko, Inc., Senseonics Holdings, Inc., ARKRAY, Inc., Nipro Corporation, Embecta Corp, and AgaMatrix, Inc.

The driving factors of the diabetes care devices market are the the increasing prevalence of diabetes and advancements in medical devices. The rising demand for effective diabetes management solutions further contributes to market growth.

North America region will lead the global diabetes care devices market during the forecast period 2025 to 2034.